The success of Biogen Idec’s (BIIB) oral multiple sclerosis (MS) treatment Tecfidera has been well documented in recent quarters, but the company is far from a one-hit wonder.
Its biggest seller is Avonex, an injectable MS treatment.
The success of Biogen Idec’s (BIIB) oral multiple sclerosis (MS) treatment Tecfidera has been well documented in recent quarters, but the company is far from a one-hit wonder.
Its biggest seller is Avonex, an injectable MS treatment.